Ferric Carboxymaltose for the Correction of Cancer- and Chemotherapy-Assiciated Anemia in Clinical Practice. 1. Juni 2011 Steinmetz, T., Tschechne, B., Virgin, G., Klement, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2011. haematologica 96(s2), 0983. Abstract Treatment of cancer- and chemotherapy-associated anemia with ferric carboxymaltose in clinical practice. Steinmetz, T., Tschechne, B., Harlin, O., Klement, B., Franzem, M., Wamhoff, J., Tech, H., Rohrberg, R., Marschner, N., 2011. Onkologie 34 (suppl 6)(V1012), 304. doi:10.1159/000333303… Weiterlesen Effectiveness and tolerability of ferric carboymaltose in the correction of cancer- and chemotherapy-associated anaemia – a multicenter observational study. Steinmetz, T., Tschechne, B., Virgin, G., Klement, B., Rzychon, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2011. chemotherapy-associated anaemia – a… Weiterlesen